Home LiteratureArticle Details
PMID: 3552996 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Infection and immunity ·Vol. 55 ·No. 5 ·1987-05-00 ·Pages 1243-51

Payne NR, Kim YK, Ferrieri P

Abstract

The influence of antibody and complement on the polymorphonuclear leukocytic uptake and killing of type II group B streptococci (GBS) was examined with 11 adult sera and three type II strains possessing the trypsin-resistant and trypsin-sensitive components (II/TR+TS) of the "c" (formerly Ibc) protein or two type II strains lacking both components (II/no c) of the c protein. All tested sera mediated a greater than 1 log10 reduction in colony-forming units (CFUR) of a type II/no c strain, even in the absence of measurable type-specific antibody (less than 1.08 micrograms/ml), but only 5 of 11 mediated a greater than 1 log10 CFUR of any type II/TR/TS strain, even in the presence of moderate levels of type-specific antibody. The classical pathway of complement activation appeared to be more important than the alternative pathway, and even absorbed or immunoglobulin G (IgG)-depleted serum (IgG, 10 mg/dl) mediated a greater than 1 log10 CFUR without magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (magnesium EGTA) chelation. Chelation with magnesium EGTA reduced the CFUR in 4 of 11 test sera and greatly reduced the CFUR in absorbed or IgG-depleted sera for type II/no c strains. Despite variation in the phagocytic killing of two representative strains of type II GBS, both strains were well phagocytized, as measured by radiolabeled bacterial uptake or electron microscopy. This study suggested that poorly killed type II/TR+TS GBS were easily phagocytized but apparently resisted intracellular killing.

MeSH Terms
Antibodies, Bacterial/immunology Bacterial Proteins/immunology Blood Bactericidal Activity Complement Pathway, Classical Complement System Proteins/immunology Humans In Vitro Techniques Neutrophils/immunology,microbiology,ultrastructure Opsonin Proteins/immunology Phagocytosis Species Specificity Streptococcus agalactiae/classification,immunology
Chemicals
Antibodies, Bacterial Bacterial Proteins Opsonin Proteins Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Payne N R
Kim Y K
Ferrieri P
References (26)
26 references, click to expand
  1. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
    J Exp Med. 1975 Jul 1;142(1):165-79 PMID: 1097573
  2. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
    J Infect Dis. 1986 Jul;154(1):47-54 PMID: 3519791
  3. Role of antibody and complement in opsonization of group B streptococci.
    Infect Immun. 1978 Jul;21(1):34-40 PMID: 101462
  4. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Pediatr Res. 1981 Dec;15(12):1525-9 PMID: 7033908
  5. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
    J Immunol. 1979 May;122(5):1994-9 PMID: 376729
  6. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
    J Infect Dis. 1979 Dec;140(6):1004-8 PMID: 396335
  7. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.
    Infect Immun. 1980 Mar;27(3):1023-32 PMID: 6991426
  8. Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.
    Br J Exp Pathol. 1981 Aug;62(4):393-7 PMID: 7028073
  9. Variations in the opsonic requirements of group B streptococcus type III.
    Br J Exp Pathol. 1981 Oct;62(5):519-25 PMID: 7028075
  10. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    J Clin Invest. 1982 Feb;69(2):394-404 PMID: 7035495
  11. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    J Immunol. 1982 Apr;128(4):1897-902 PMID: 7037956
  12. Strain differences in virulence of group B streptococci.
    Pediatr Res. 1982 May;16(5):347-50 PMID: 7048229
  13. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.
    Infect Immun. 1983 Mar;39(3):1243-51 PMID: 6341233
  14. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.
    J Infect Dis. 1983 May;147(5):857-63 PMID: 6341485
  15. Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.
    Acta Pathol Microbiol Immunol Scand B. 1983 Apr;91(2):145-51 PMID: 6346797
  16. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.
    J Clin Invest. 1983 Jul;72(1):260-9 PMID: 6192144
  17. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    J Clin Invest. 1983 Aug;72(2):560-73 PMID: 6348093
  18. Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.
    Infect Immun. 1984 Apr;44(1):124-9 PMID: 6423540
  19. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.
    J Clin Microbiol. 1984 Apr;19(4):506-10 PMID: 6201506
  20. Potentiation of virulence by group B streptococcal polysaccharides.
    J Infect Dis. 1984 Jun;149(6):851-60 PMID: 6376652
  21. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    J Infect Dis. 1984 Jul;150(1):63-70 PMID: 6379061
  22. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen.
    J Exp Med. 1984 Nov 1;160(5):1467-75 PMID: 6387034
  23. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.
    J Infect Dis. 1985 Apr;151(4):672-81 PMID: 3882857
  24. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
    Infect Immun. 1985 Jul;49(1):19-24 PMID: 3891622
  25. Immunoelectron microscopical demonstration of the cell wall and capsular antigens of GBS.
    Antibiot Chemother (1971). 1985;35:119-27 PMID: 3901889
  26. Breakdown products of C3 and factor B in hemolytic-uremic syndrome.
    J Lab Clin Med. 1977 Apr;89(4):845-50 PMID: 845484
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1987-05-00
Pages
1243-51
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260497
Subset
IM
Grants
NIAID NIH HHS · 5T32 AI-07054 · United States
NIAID NIH HHS · AI-13926 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com